Latest Articles
BBC The Traitors star opens up about dealing with crippling condition while on show - Surrey Live
BBC The Traitors star opens up about dealing with crippling condition while on show Surrey Live
Published: Jan. 20, 2025, 1:07 p.m.
'Two things that helped my crippling health condition on BBC's The Traitors' - Yahoo News UK
'Two things that helped my crippling health condition on BBC's The Traitors' Yahoo News UK
Published: Jan. 20, 2025, 1:04 p.m.
GSK’s Jemperli combination approved by EC for expanded endometrial cancer use - PMLiVE
GSK’s Jemperli combination approved by EC for expanded endometrial cancer use PMLiVE
Published: Jan. 20, 2025, 12:33 p.m.
'I suffered a crippling health condition during the filming of BBC's The Traitors' - Yahoo News UK
'I suffered a crippling health condition during the filming of BBC's The Traitors' Yahoo News UK
Published: Jan. 20, 2025, 11:17 a.m.
'I suffered a crippling health condition during the filming of BBC's The Traitors' - Wales Online
'I suffered a crippling health condition during the filming of BBC's The Traitors' Wales Online
Published: Jan. 20, 2025, 11:17 a.m.
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Jan. 20, 2025, 10:56 a.m.
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment - beQuoted
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment beQuoted
Published: Jan. 20, 2025, 8:21 a.m.
GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment - DirectorsTalk Interviews
GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment DirectorsTalk Interviews
Published: Jan. 20, 2025, 7:28 a.m.
GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment - TipRanks
GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment TipRanks
Published: Jan. 20, 2025, 7:19 a.m.
GSK’s Jemperli wins EU nod for broader use in front-line endometrial cancer - FirstWord Pharma
GSK’s Jemperli wins EU nod for broader use in front-line endometrial cancer FirstWord Pharma
Published: Jan. 20, 2025, 7:14 a.m.
Link copied to clipboard!